Experimental antiviral proves effective in halting spread and damage of COVID-19

After early success, India’s daily COVID infections have surpassed the US and Brazil. Why?
16 April 2021
Tuberculosis study reveals a new lineage of disease in eastern Africa
16 April 2021

Experimental antiviral proves effective in halting spread and damage of COVID-19

An experimental antiviral drug can significantly decrease levels of the virus causing COVID-19 and the damage it causes in the lungs, according to new research.

Comments are closed.